Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Global Forecast 2024-2030

Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Global Forecast 2024-2030


The Dry Eye Syndrome Market size was estimated at USD 4.39 billion in 2023 and expected to reach USD 4.71 billion in 2024, at a CAGR 7.21% to reach USD 7.16 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Dry Eye Syndrome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dry Eye Syndrome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Dry Eye Syndrome Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Alcon Vision LLC, Bausch & Lomb Pvt Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Mitotech S.A., Nicox S.A., Novartis AG, Otsuka Holdings Co, Prestige Consumer Healthcare, Santen Pharmaceutical Co.ltd, Sentiss Pharma Pvt. Ltd, and Sun Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug
Anti-inflammatory Drugs

Autologous Serum Eye Drops

Lubricant Eye Drops
Product
Eye Ointment

Gel

Liquid Drops

Liquid Wipes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Dry Eye Syndrome Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dry Eye Syndrome Market?
3. What are the technology trends and regulatory frameworks in the Dry Eye Syndrome Market?
4. What is the market share of the leading vendors in the Dry Eye Syndrome Market?
5. Which modes and strategic moves are suitable for entering the Dry Eye Syndrome Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Dry Eye Syndrome Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of dry eye diseases
5.1.1.2. Growing awareness regarding diagnosis and treatment of the disease
5.1.1.3. Rising geriatric population across the world
5.1.2. Restraints
5.1.2.1. Stringent regulatory process
5.1.3. Opportunities
5.1.3.1. Development of novel technologies
5.1.3.2. Increase in R&D investment
5.1.4. Challenges
5.1.4.1. Increase in product recall
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Dry Eye Syndrome Market, by Drug
6.1. Introduction
6.2. Anti-inflammatory Drugs
6.3. Autologous Serum Eye Drops
6.4. Lubricant Eye Drops
7. Dry Eye Syndrome Market, by Product
7.1. Introduction
7.2. Eye Ointment
7.3. Gel
7.4. Liquid Drops
7.5. Liquid Wipes
8. Americas Dry Eye Syndrome Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Dry Eye Syndrome Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Dry Eye Syndrome Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. AFT Pharmaceuticals
12.1.3. Akorn Operating Company LLC
12.1.4. Alcon Vision LLC
12.1.5. Bausch & Lomb Pvt Ltd.
12.1.6. GlaxoSmithKline PLC
12.1.7. Johnson & Johnson Services, Inc.
12.1.8. Mitotech S.A.
12.1.9. Nicox S.A.
12.1.10. Novartis AG
12.1.11. Otsuka Holdings Co
12.1.12. Prestige Consumer Healthcare
12.1.13. Santen Pharmaceutical Co.ltd
12.1.14. Sentiss Pharma Pvt. Ltd
12.1.15. Sun Pharmaceutical Industries Ltd
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. DRY EYE SYNDROME MARKET RESEARCH PROCESS
FIGURE 2. DRY EYE SYNDROME MARKET SIZE, 2023 VS 2030
FIGURE 3. DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRY EYE SYNDROME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRY EYE SYNDROME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRY EYE SYNDROME MARKET DYNAMICS
FIGURE 7. DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 8. DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings